Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Farfetch. We will start...
— Christina Siegel Malbon
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Farfetch
No other institutional pitches found for this ticker yet.
More institutional theses from Patient Capital Management
Precigen is an undervalued cell and gene therapy company poised for its first FDA approval later this year. A recent private...
The fund initiated a position in the Bitcoin ETF, believing the digital asset is still in the early stages of its adoption lifecycle. Despite its recent...
Expedia Group experienced a sharp upward re-rating in Q4 after lagging for most of the year despite strong underlying business fundamentals. The fund successfully...